Microfluidic strategies for the isolation and profiling of exosomes

J Bai, X Wei, X Zhang, C Wu, Z Wang, M Chen… - TrAC Trends in …, 2023 - Elsevier
Exosomes are nanoscale extracellular vesicles carrying various cargos, which play a
significant rule in intercellular communication, disease diagnosis and treatment …

Organs-on-a-chip: a union of tissue engineering and microfabrication

Y Zhao, EY Wang, FBL Lai, K Cheung, M Radisic - Trends in biotechnology, 2023 - cell.com
We review the emergence of the new field of organ-on-a-chip (OOAC) engineering, from the
parent fields of tissue engineering and microfluidics. We place into perspective the tools and …

[HTML][HTML] Tumor-on-chip modeling of organ-specific cancer and metastasis

N Del Piccolo, VS Shirure, Y Bi… - Advanced drug delivery …, 2021 - Elsevier
Every year, cancer claims millions of lives around the globe. Unfortunately, model systems
that accurately mimic human oncology–a requirement for the development of more effective …

Recent advances for cancer detection and treatment by microfluidic technology, review and update

N Bargahi, S Ghasemali, S Jahandar-Lashaki… - Biological Procedures …, 2022 - Springer
Numerous cancer-associated deaths are owing to a lack of effective diagnostic and
therapeutic approaches. Microfluidic systems for analyzing a low volume of samples offer a …

Design and fabrication of organ-on-chips: promises and challenges

A Tajeddin, N Mustafaoglu - Micromachines, 2021 - mdpi.com
The advent of the miniaturization approach has influenced the research trends in almost all
disciplines. Bioengineering is one of the fields benefiting from the new possibilities of …

Engineered biomimetic membranes for organ-on-a-chip

M Rahimnejad, F Rasouli, S Jahangiri… - ACS Biomaterials …, 2022 - ACS Publications
Organ-on-a-chip (OOC) systems are engineered nanobiosystems to mimic the
physiochemical environment of a specific organ in the body. Among various components of …

Engineering prostate cancer in vitro: what does it take?

A Buskin, E Scott, R Nelson, L Gaughan, CN Robson… - Oncogene, 2023 - nature.com
A key challenge in the clinical management and cause of treatment failure of prostate cancer
(PCa) is its molecular, cellular and clinical heterogeneity. Modelling systems that fully …

Advances of nanomedicines in breast cancer metastasis treatment targeting different metastatic stages

W Yu, C Hu, H Gao - Advanced Drug Delivery Reviews, 2021 - Elsevier
Breast cancer is the most common tumor in women, and the metastasis further increases the
malignancy with extremely high mortality. However, there is almost no effective method in …

Joint-on-chip platforms: entering a new era of in vitro models for arthritis

CA Paggi, LM Teixeira, S Le Gac… - Nature Reviews …, 2022 - nature.com
Arthritis affects millions of people worldwide. With only a few disease-modifying drugs
available for treatment of rheumatoid arthritis and none for osteoarthritis, a clear need exists …

Supramolecular Polymer‐Nanomedicine Hydrogel Loaded with Tumor Associated Macrophage‐Reprogramming polyTLR7/8a Nanoregulator for Enhanced Anti …

X Liu, Y Huangfu, J Wang, P Kong, W Tian… - Advanced …, 2023 - Wiley Online Library
Anti‐angiogenic therapies targeting inhibition of vascular endothelial growth factor (VEGF)
pathway show clinical benefit in hypervascular hepatocellular carcinoma (HCC) tumors …